Last reviewed · How we verify
EuTCV
At a glance
| Generic name | EuTCV |
|---|---|
| Sponsor | EuBiologics Co.,Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants (PHASE2, PHASE3)
- Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |